Abstract:Advances in nanomedicine have led to the development of efficient ways of dosing biologically active molecules through the use of nanocarriers for the treatment of several diseases, such as tumors, diabetes, neurodegenerative diseases, among others; although several studies have shown that the use of nanocarriers has overcome conventional drug delivery limitations, the limited number of nanotechnological drugs available has raised the curiosity of many researchers in the quest for improvements in nanomedicines. Indeed, recent studies have shown that knowledge of human physiological barriers can be useful to improve the design of nano-drugs, optimizing the delivery of active ingredients in situ. Among these barriers are the physiological and pathological differences between animal model specimens and humans, which makes it difficult to transpose in vivo results to the clinical scenario, intra-patient and inter-patient heterogeneity, and other factors. With the various advantages offered by precision or personalized medicine through the use of exosomes and/or nanoparticles designed for the patient, the problems that constitute the physiological barriers have been solved only at the level of the individual, leaving on the other hand the barrier constituted by population heterogeneity. According to several authors, an adequate design of nano-drugs by incorporating targeting complexes on their surface could facilitate the transfer of animal studies to humans, increase the lifetime of the drug in circulation in the body, optimize its specific delivery, and overcome multiple biological barriers at both the individual and population level. In line with the discussion above, this review highlights the importance of novel nanocarrier systems as solutions to overcome biological barriers that limit therapeutic efficacy.

Smart Nanosystems for Overcoming Multiple Biological Barriers in Cancer Nanomedicines Transport: Design Principles, Progress, and Challenges

“Smart” Nanocarriers: A New Paradigm for Tumor Targeting Drug Delivery Systems

Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management

Design of Nanocarriers Based on Complex Biological Barriers in Vivo for Tumor Therapy

Smart and bioinspired systems for overcoming biological barriers and enhancing disease theranostics

Advanced Engineered Nanoparticulate Platforms to Address Key Biological Barriers for Delivering Chemotherapeutic Agents to Target Sites.

Smart Nanoparticles Improve Therapy for Drug-Resistant Tumors by Overcoming Pathophysiological Barriers

Smart nanocarriers for cancer treatment: Clinical impact and safety

Overcoming tumor and mucosal barriers through active-loaded nanocarriers: nanoparticles and exosomes

Intelligent nanomaterials for cancer therapy: recent progresses and future possibilities

Strategies of overcoming the physiological barriers for tumor-targeted nano-sized drug delivery systems.

Recent Advances in Drug Delivery Systems for Enhancing Drug Penetration into Tumors

Overcoming the Biological Barriers in the Tumor Microenvironment for Improving Drug Delivery and Efficacy

Engineering nanoparticles to tackle tumor barriers

Transport Barriers and Strategies of Antitumor Nanocarriers Delivery System

'Smart' Nanoparticles As Drug Delivery Systems for Applications in Tumor Therapy.

Smart Drug-Delivery Systems for Cancer Nanotherapy

Biologically based strategies for overcoming in vivo barriers with functional nano-delivery systems

Cancer Therapy Based on Smart Drug Delivery with Advanced Nanoparticles

Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release

New Nanomaterials and Techniques for Tumor-targeted Systems